Skip to main content
Year archive

Vivoryon Therapeutics N.V. — 2017 filings

All 25 regulatory filings released by Vivoryon Therapeutics N.V. (VVY) in 2017, sourced directly from the official regulator.

25 Filings
2017 Period
2017 filings (25)
Filing Released Lang
Probiodrug AG: Probiodrug and Crossbeta Biosciences extend their strategic partnership in the field of Alzheimer's disease biomarkers
Regulatory Filings
2017-12-05 English
CORRECTION: Probiodrug AG: Probiodrug reports Third Quarter 2017 Business Update
Interim / Quarterly Report Q3 2017
2017-11-30 English
Probiodrug AG: Probiodrug reports Third Quarter 2017 Business Update
Interim / Quarterly Report Q3 2017
2017-11-30 English
Probiodrug : Probiodrug AG to Publish its Third Quarter 2017 Business Update on 30 November 2017
Report Publication Announcement
2017-11-23 English
Probiodrug to Present Data from its Phase 2a SAPHIR Study at International Alzheimer's Disease Conference
Regulatory Filings
2017-10-26 English
Probiodrug initiates Phase 2b core program of PQ912 and details further strategy
Regulatory Filings
2017-10-16 English
Probiodrug reports financial results for H1 2017 and corporate update
Interim / Quarterly Report H1 2017
2017-08-31 English
Unique binding mode of PBD-C06 to pGlu-Abeta peptides identified
Earnings Release Q3 2017
2017-08-29 English
Probiodrug AG to Publish First Half 2017 Results on 31 August 2017
Report Publication Announcement
2017-08-24 English
Report Publication Announcement 2017
Report Publication Announcement
2017-08-24 English
Ordinary General Meeting of Shareholders of Probiodrug AG
AGM Information
2017-06-14 English
Probiodrug AG Announces Acceptance of PQ912 Pharmacology Paper by Peer Reviewed Journal
Regulatory Filings
2017-05-16 English
Probiodrug AG reports First Quarter 2017 Business Update
Interim / Quarterly Report Q1 2017
2017-05-12 English
Probiodrug AG to Publish its First Quarter 2017 Business Update on 12 May 2017
Report Publication Announcement
2017-05-05 English
Probiodrug AG to hold its Ordinary General Meeting of Shareholders on 13 June 2017
AGM Information
2017-05-03 English
Probiodrug AG: Bekanntmachung der Einberufung zur Hauptversammlung am 13.06.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2017-05-02 German
Probiodrug to present at Huntington's Disease Therapeutics Conference
Regulatory Filings
2017-04-10 English
Last Patient Last Visit (LPLV) reached in the SAPHIR Study
Earnings Release Q2 2017
2017-04-07 English
Probiodrug reports full year 2016 financial results
Earnings Release FY 2016
2017-03-30 English
Probiodrug to present at Alzheimer's and Parkinson's Diseases Congress
Regulatory Filings
2017-03-28 English
Report Publication Announcement 2017
Report Publication Announcement
2017-03-23 English
Probiodrug AG to Publish its Full Year 2016 Results on 30 March 2017
Report Publication Announcement
2017-03-23 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-02-06 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-02-03 English
Probiodrug announces completion of recruitment for the SAPHIR Phase 2a study of Glutaminyl Cyclase Inhibitor PQ912 in early Alzheimer's disease patients
Regulatory Filings
2017-01-09 English